{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:10:55Z","timestamp":1770966655550,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The 2019 Coronavirus disease (Covid-19) has affected thousands of people worldwide. To date, vaccines appear to be the only method to prevent and reduce mortality. Four vaccinations have been outwardly approved by European Medicine Agency (EMA) in Europe: BNT162b2 (Comirnaty-BioNTech\/Pfizer), mRNA-1273 (Spikevax-Moderna), ChAdOx1 (VaxzevriaAstrazeneca), and Ad26.COV2-S (Janssen-Johnson&amp;Johnson). After vaccination, local and systemic adverse effects can occur. Cutaneous reactions like urticaria, local injection site pain, morbilliform rash have been documented after vaccination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Cases presentation<\/jats:title>\n                <jats:p>We report four cases of oral erythema multiforme flare arising after BNT162b2 vaccination administration. All the patients denied previous erythema-like and herpetic manifestations history. Two of the reported cases (number 1 and 2) presented with both oral and cutaneous lesions, while cases 3 and 4 showed only oral manifestations. Three of the cases presented the erythema after the first vaccination dosage administration, only one case reported lesions after the second vaccination dosage administration. All the cases were treated with prednisone via oral administration and topical 0.05% clobetasol ointment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present reports represent some of the few cases of erythema multiforme occurring as a side effect of the BNT162b2 COVID-19 vaccination. The causal role of the vaccine for the erythema multiforme has not been proven yet; nevertheless, it is not uncommon for medications to trigger this disease. The vaccine could surface a silent herpes virus infection, which would induce the erythema multiforme instead.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12903-022-02124-2","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T11:15:54Z","timestamp":1648206954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases"],"prefix":"10.1186","volume":"22","author":[{"given":"Massimo","family":"Petruzzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Galleggiante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6467-2039","authenticated-orcid":false,"given":"Fedora","family":"della Vella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"issue":"1","key":"2124_CR1","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1038\/s41598-021-82850-9","volume":"11","author":"K Nakamichi","year":"2021","unstructured":"Nakamichi K, Shen JZ, Lee CS, Lee A, Roberts EA, Simonson PD, et al. Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19. Sci Rep. 2021;11(1):4802. https:\/\/doi.org\/10.1038\/s41598-021-82850-9.","journal-title":"Sci Rep"},{"issue":"1","key":"2124_CR2","doi-asserted-by":"publisher","first-page":"e14717","DOI":"10.1111\/dth.14717","volume":"34","author":"R Eghbali Zarch","year":"2021","unstructured":"Eghbali Zarch R, Hosseinzadeh P. COVID-19 from the perspective of dentists: a case report and brief review of more than 170 cases. Dermatol Ther. 2021;34(1):e14717. https:\/\/doi.org\/10.1111\/dth.14717.","journal-title":"Dermatol Ther"},{"issue":"2","key":"2124_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.clindermatol.2020.10.020","volume":"39","author":"MJ Lavery","year":"2021","unstructured":"Lavery MJ, Bouvier CA, Thompson B. Cutaneous manifestations of COVID-19 in children (and adults): a virus that does not discriminate. Clin Dermatol. 2021;39(2):323\u20138. https:\/\/doi.org\/10.1016\/j.clindermatol.2020.10.020.","journal-title":"Clin Dermatol"},{"issue":"1","key":"2124_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","volume":"85","author":"DE McMahon","year":"2021","unstructured":"McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46\u201355. https:\/\/doi.org\/10.1016\/j.jaad.2021.03.092.","journal-title":"J Am Acad Dermatol"},{"key":"2124_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jdcr.2021.04.014","volume":"12","author":"P Rodr\u00edguez-Jim\u00e9nez","year":"2021","unstructured":"Rodr\u00edguez-Jim\u00e9nez P, Chicharro P, Cabrera LM, Segu\u00ed M, Morales-Caballero \u00c1, et al. Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: report of 5 cases. JAAD Case Rep. 2021;12:58\u20139. https:\/\/doi.org\/10.1016\/j.jdcr.2021.04.014.","journal-title":"JAAD Case Rep"},{"issue":"8","key":"2124_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/papr.13062","volume":"21","author":"RM Chow","year":"2021","unstructured":"Chow RM, Rajput K, Howie BA, Varhabhatla N. The COVID-19 vaccine and interventional procedures: Exploring the relationship between steroid administration and subsequent vaccine efficacy. Pain Pract. 2021;21(8):966\u201373. https:\/\/doi.org\/10.1111\/papr.13062.","journal-title":"Pain Pract"},{"key":"2124_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17504","author":"R Merhy","year":"2021","unstructured":"Merhy R, Sarkis AS, Kaikati J, El Khoury L, Ghosn S, Stephan F. New-onset cutaneous lichen planus triggered by COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2021. https:\/\/doi.org\/10.1111\/jdv.17504.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2124_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17682","author":"L Borg","year":"2021","unstructured":"Borg L, Mercieca L, Mintoff D, Micallef D, Pisani D, Betts A, et al. Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme. J Eur Acad Dermatol Venereol. 2021. https:\/\/doi.org\/10.1111\/jdv.17682.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"2124_CR9","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/ced.14714","volume":"46","author":"MJ Lavery","year":"2021","unstructured":"Lavery MJ, Nawimana S, Parslew R, Stewart L. A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. Clin Exp Dermatol. 2021;46(7):1325\u20137. https:\/\/doi.org\/10.1111\/ced.14714.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"2124_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/pde.14246","volume":"37","author":"A Torrelo","year":"2020","unstructured":"Torrelo A, Andina D, Santonja C, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Trist\u00e1n J, et al. Erythema multiforme-like lesions in children and COVID-19. Pediatr Dermatol. 2020;37(3):442\u20136. https:\/\/doi.org\/10.1111\/pde.14246.","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"2124_CR11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/ced.14281","volume":"45","author":"J Jimenez-Cauhe","year":"2020","unstructured":"Jimenez-Cauhe J, Ortega-Quijano D, Carretero-Barrio I, Suarez-Valle A, Saceda-Corralo D, Moreno-Garcia Del Real C, et al. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings. Clin Exp Dermatol. 2020;45(7):892\u20135. https:\/\/doi.org\/10.1111\/ced.14281.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"2124_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13779","volume":"33","author":"L Gargiulo","year":"2020","unstructured":"Gargiulo L, Pavia G, Facheris P, Valenti M, Sacrini F, Narcisi A, et al. A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever. Dermatol Ther. 2020;33(4): e13779. https:\/\/doi.org\/10.1111\/dth.13779.","journal-title":"Dermatol Ther"},{"issue":"10223","key":"2124_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"China Lancet"},{"issue":"2","key":"2124_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1365-2230.2000.00601.x","volume":"25","author":"F Loche","year":"2000","unstructured":"Loche F, Schwarze HP, Thedenat B, Carriere M, Bazex J. Erythema multiforme associated with hepatitis B immunization. Clin Exp Dermatol. 2000;25(2):167\u20138. https:\/\/doi.org\/10.1046\/j.1365-2230.2000.00601.x.","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"2124_CR15","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1592\/phco.26.11.1658","volume":"26","author":"J Studdiford","year":"2006","unstructured":"Studdiford J, Oppenheim L, McCann E, Altshuler M. Erythema multiforme after meningitis vaccine: patient safety concerns with repeat immunization. Pharmacotherapy. 2006;26(11):1658\u201361. https:\/\/doi.org\/10.1592\/phco.26.11.1658.","journal-title":"Pharmacotherapy"},{"issue":"4","key":"2124_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s13365-013-0189-3","volume":"19","author":"KP Egan","year":"2013","unstructured":"Egan KP, Wu S, Wigdahl B, Jennings SR. Immunological control of herpes simplex virus infections. J Neurovirol. 2013;19(4):328\u201345. https:\/\/doi.org\/10.1007\/s13365-013-0189-3.","journal-title":"J Neurovirol"},{"issue":"7868","key":"2124_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","volume":"595","author":"U Sahin","year":"2021","unstructured":"Sahin U, Muik A, Vogler I, Derhovanessian E, Kranz LM, Vormehr M, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595(7868):572\u20137. https:\/\/doi.org\/10.1038\/s41586-021-03653-6.","journal-title":"Nature"},{"issue":"25","key":"2124_CR18","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","volume":"383","author":"EJ Anderson","year":"2020","unstructured":"Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med. 2020;383(25):2427\u201338. https:\/\/doi.org\/10.1056\/NEJMoa2028436.","journal-title":"N Engl J Med"},{"issue":"8","key":"2124_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41577-021-00578-z","volume":"21","author":"M Sadarangani","year":"2021","unstructured":"Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol. 2021;21(8):475\u201384. https:\/\/doi.org\/10.1038\/s41577-021-00578-z.","journal-title":"Nat Rev Immunol"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-022-02124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-022-02124-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-022-02124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T11:24:53Z","timestamp":1648207493000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-022-02124-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2124"],"URL":"https:\/\/doi.org\/10.1186\/s12903-022-02124-2","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"27 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki guidelines. All treatment was performed after obtaining the patients\u2019 or the tutors\u2019 consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of this case report and any accompanying images was obtained from all the three patients and from the parent of the case two patient. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MP has no competing interests to declare. SG has no competing interests to declare. SM has no competing interests to declare. FDV has no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}